[HTML][HTML] Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

F Scaldaferri, C Correale, A Gasbarrini… - World journal of …, 2010 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the bowel,
including ulcerative colitis and Crohn's disease. A single etiology has not been identified …

Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology

J Florholmen, W Fries - Scandinavian journal of gastroenterology, 2011 - Taylor & Francis
Objective. There is increasing knowledge of the pathophysiology behind inflammatory bowel
disease (IBD) although the exact mechanism is far from fully understood. In the era of new …

Biomarkers of inflammatory bowel disease: from classical laboratory tools to personalized medicine

E Viennois, Y Zhao, D Merlin - Inflammatory bowel diseases, 2015 - academic.oup.com
Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Biomarkers in inflammatory bowel disease

SW Beaven, MT Abreu - Current opinion in gastroenterology, 2004 - journals.lww.com
Biomarkers in inflammatory bowel disease : Current Opinion in Gastroenterology Biomarkers
in inflammatory bowel disease : Current Opinion in Gastroenterology Log in or Register …

[HTML][HTML] Laboratory markers in ulcerative colitis: Current insights and future advances

M Cioffi, A De Rosa, R Serao, I Picone… - World journal of …, 2015 - ncbi.nlm.nih.gov
Ulcerative colitis (UC) and Crohn's disease (CD) are the major forms of inflammatory bowel
diseases (IBD) in man. Despite some common features, these forms can be distinguished by …

Biomarkers in management of inflammatory bowel disease

A Moniuszko, A Wiśniewska… - Gastroenterology Review …, 2013 - termedia.pl
In recent years the use of faecal and serologic biomarkers has been evaluated in the
diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) …

New biomarkers for diagnosing inflammatory bowel disease and assessing treatment outcomes

EL Barnes, R Burakoff - Inflammatory bowel diseases, 2016 - academic.oup.com
Despite advances in our understanding of the pathophysiology underlying inflammatory
bowel disease, there remains a significant need for biomarkers that can differentiate …

An update on diagnostic and prognostic biomarkers in inflammatory bowel disease

AS Day, ST Leach, DA Lemberg - Expert Review of Molecular …, 2017 - Taylor & Francis
Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

[HTML][HTML] Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment

M Norouzinia, V Chaleshi, AHM Alizadeh… - … and Hepatology from …, 2017 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic disease of unknown etiology which mostly
involves the intestine and requires a personalized approach for treatment. IBD represents a …

Biological markers in inflammatory bowel disease: practical consideration for clinicians

JL Mendoza, MT Abreu - Gastroenterologie clinique et biologique, 2009 - Elsevier
The biomarkers are important in the Inflammatory Bowel Disease (IBD) to gain an objective
measurement of disease activity and severity, as well as prognostic indicator and outcome of …